Parker Hannifin (PH)
NYSEIndustrialsSpecialty Industrial MachinerySnapshot 2026-07-07
$957.51-1.43%
Close 2026-07-07 · 1-day change
Reading PH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track PH free→NYSEIndustrialsSpecialty Industrial MachinerySnapshot 2026-07-07
Reading PH? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track PH free→QuarterlyIQ Insights · PH
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $957.51. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $958 PH trades at 31× p/e, below its 31× p/e peer median, but our blended $779 fair value sits below the price. We hold it with medium confidence: our number sits below the analyst range. Analysts target $950–$1,269. Note: our $779 fair value sits below the entire analyst range ($950–$1,269). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $1057.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $796.68 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $767.71 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $110.58 | — | — | TTM | high |
| graham number | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$950.00 – $1269.00 (median $1057.00) · 8 analysts · as of 2026-07-02
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 107% over what the business is worth with no growth; closing that gap needs roughly 21.0 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $27.97/sh owner earnings.
Roughly priced in line with peers.
Richer than its own typical valuation.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $280.99 |
| — |
| — |
| TTM |
| high |
| Mgmt guidance | 12M | $911.25 | 31.3 | 29.15 | Mgmt | high |
| Peer P/FCF | 12M | $770.36 | 26.8 | 28.74 | TTM | high |
| Peer P/E | 12M | $960.64 | 31.3 | 30.73 | TTM | high |
| Peer P/S | 12M | $475.46 | 2.9 | 163.96 | TTM | high |
| PEG | 12M | $1046.76 | 34.1 | 30.73 | TTM | high |
| residual income | 12M | $192.21 | — | — | TTM | high |
| Own P/E history | 12M | $844.02 | 27.5 | 30.73 | TTM | high |
| triangulated | 12M | $1016.46 | 31.3 | 32.52 | Triangulated | high |
| Mgmt guidance | 3Y | $1254.88 | 31.3 | 40.14 | Mgmt(prov.) | medium |
| Peer P/FCF | 3Y | $1171.63 | 26.8 | 43.71 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $1135.58 | 31.3 | 36.33 | Analyst | medium |
| Peer P/S | 3Y | $546.44 | 2.9 | 188.44 | guidance | medium |
| PEG | 3Y | $1237.38 | 34.1 | 36.33 | Analyst | medium |
| Own P/E history | 3Y | $997.72 | 27.5 | 36.33 | Analyst | medium |
| Mgmt guidance | 5Y | $1553.27 | 31.3 | 49.69 | Mgmt(prov.) | high |
| Peer P/FCF | 5Y | $1549.48 | 26.8 | 57.80 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $1288.00 | 31.3 | 41.20 | Analyst | high |
| Peer P/S | 5Y | $619.78 | 2.9 | 213.73 | guidance | high |
| PEG | 5Y | $1403.47 | 34.1 | 41.20 | Analyst | high |
| Own P/E history | 5Y | $1131.64 | 27.5 | 41.20 | Analyst | high |